MYOK Key Statistics, Chart & Performance
The current stock price of MYOK is 224.91 null. In the past month the price increased by 1.34%. In the past year, price increased by 267.02%.
MYOK Latest News, Press Relases and Analysis
About MYOK
Company Profile
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.
Company Info
Myokardia Inc
1000 SIERRA POINT PARKWAY
BRISBANE CA 94005
CEO: T. Anastasios Gianakakos
Phone: 650-741-0900
Myokardia Inc / MYOK FAQ
What does Myokardia Inc do?
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.
What is the current price of MYOK stock?
The current stock price of MYOK is 224.91 null. The price increased by 0.05% in the last trading session.
What is the dividend status of Myokardia Inc?
MYOK does not pay a dividend.
What is the ChartMill technical and fundamental rating of MYOK stock?
MYOK has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is Myokardia Inc worth?
Myokardia Inc (MYOK) has a market capitalization of 11.99B null. This makes MYOK a Large Cap stock.
MYOK Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MYOK. When comparing the yearly performance of all stocks, MYOK is one of the better performing stocks in the market, outperforming 98.38% of all stocks.
MYOK Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MYOK. No worries on liquidiy or solvency for MYOK as it has an excellent financial health rating, but there are worries on the profitability.
MYOK Financial Highlights
Over the last trailing twelve months MYOK reported a non-GAAP Earnings per Share(EPS) of -5.640000000000001. The EPS decreased by -61.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.74% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |